A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors

NCT06906731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-9803

Sponsor

Jiangsu HengRui Medicine Co., Ltd.